Both in Biotechnology
4D Molecular Therapeutics vs Entera Bio
Over the past year FDMT returned +1.3% and ENTX returned +8.8%; their daily moves had a correlation of 0.21.
FDMT +1.3% ENTX +8.8%Growth of $1, one year, split-adjusted
| Metric | FDMT | ENTX |
|---|---|---|
| Price | $11.37 | $3.09 |
| Market cap | $628.1M | $537.4M |
| Today | −4.45% | −3.44% |
| 1 month | −16.8% | +8.0% |
| 6 months | +20.4% | +178.4% |
| Year to date | +51.6% | +59.3% |
| 1 year | +0.4% | +9.6% |
| Revenue growth (YoY) | +25106.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1929.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.8× | — |
| Net cash | $341.7M | $11.0M |
| Dividend yield | — | — |
| Volatility (60d) | 75.9% | 62.2% |
| Short % of float | 21.6% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).